Trends and disparities in sepsis-related mortality among patients with lung cancer: A 25-year nationwide analysis.

P Pranav Vempati (Rangaraya Medical College, Kakinada, India) B Bhaskar Kambhampati (Rangaraya Medical College, Andhra Pradesh, Kakinada, India) B Bhanuprakash Reddy Bathula (NTR university of Health Sciences, Rangaraya Medical college, Kakinada, India) G Gaurav Kansal (Government Medical College Patiala, Patiala, India) L Leela lakshmi sai srinivas Parasa (Rangaraya Medical College, Andhra Pradesh, Kakinada, India) M Medhansh Biradar (All India Institute of Medical sciences, Raipur, Raipur, India) T Teja Sureddi (3Virtua Health, Camden, United States)

Abstract

e20682 Background: Lung cancer patients face heightened sepsis susceptibility due to disease-related immune dysfunction and treatment-induced myelosuppression. Despite advances in sepsis management, population trends and disparities in sepsis-related mortality among this population remain poorly characterized. Methods: We conducted a retrospective analysis using the CDC WONDER database (1999-2023) for adults aged ≥25 years where both sepsis (ICD-10: A40-A41) and malignant neoplasm of lung (C34) were listed among the causes of death. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated. Temporal trends were analyzed using Joinpoint regression to determine annual percentage change (APC) and average annual percentage change (AAPC). Results were stratified by sex, age group (25-44, 45-64, ≥65 years), race/ethnicity, urbanization status, census region, and state. Results: From 1999-2023, 104,034 sepsis-related deaths occurred among lung cancer patients. AAMR increased significantly from 1.61 (95% CI: 1.55-1.66) to 2.05 (95% CI: 2.00-2.10), with an overall AAPC of 1.15 (95% CI: 0.20-2.11; p = 0.018). Joinpoint analysis identified significant increases from 1999-2013 (APC: 0.96; 95% CI: 0.56-1.36), followed by attenuation of trends and a non-significant plateau from 2016-2023 (APC: 0.42; 95% CI: -0.51-1.36). Although males had higher AAMR than females (2.48 vs 1.70 in 2023), females demonstrated significantly steeper temporal increases (AAPC: 1.93; 95% CI: 1.73-2.13 vs 0.44; 95% CI: -0.23-1.11). Adults ≥65 years showed significant increases (AAPC: 1.46; 95% CI: 1.31-1.62; p < 0.001). Black or African American individuals had the highest AAMR (2.69 in 2023), followed by Whites (2.18), Asian/Pacific Islanders (1.54), and Hispanics (1.06). Whites exhibited the fastest increase (AAPC: 1.52; 95% CI: 0.75-2.28). Non-metropolitan areas showed significantly higher AAPC (2.40; 95% CI: 1.41-3.41) versus metropolitan areas (0.95; 95% CI: 0.74-1.16), indicating widening rural-urban disparities. Regionally, the South had the highest AAMR (2.38) while the Midwest exhibited the fastest increase (AAPC: 1.78; 95% CI: 1.54-2.02). State-level AAMR ranged from Kentucky (3.08) and West Virginia (3.04) to Utah (0.66) and Wyoming (0.88). The majority of deaths (87.0%) occurred in inpatient medical facilities. Conclusions: This 25-year nationwide analysis reveals a significant rise in sepsis-related mortality among lung cancer patients with pronounced demographic and geographic disparities. Females, rural residents, and populations in Southern and Midwestern states represent vulnerable groups requiring targeted sepsis prevention and early intervention strategies.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (7)

P

Pranav Vempati

Rangaraya Medical College, Kakinada, India

B

Bhaskar Kambhampati

Rangaraya Medical College, Andhra Pradesh, Kakinada, India

B

Bhanuprakash Reddy Bathula

NTR university of Health Sciences, Rangaraya Medical college, Kakinada, India

G

Gaurav Kansal

Government Medical College Patiala, Patiala, India

L

Leela lakshmi sai srinivas Parasa

Rangaraya Medical College, Andhra Pradesh, Kakinada, India

M

Medhansh Biradar

All India Institute of Medical sciences, Raipur, Raipur, India

T

Teja Sureddi

3Virtua Health, Camden, United States